A phase II trial of endoscopic submucosal dissection (ESD) for superficial pharyngeal cancer
Not Applicable
Recruiting
- Conditions
- superficial pharyngeal cancer
- Registration Number
- JPRN-UMIN000003623
- Lead Sponsor
- Osaka Medical Center for Cancer and Cardiovascular Diseases
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
1)Patients with hematologicalabnormality 2)Active synchronous or metachronous malignancy 3)Patients with severe organ failure 4)Others who were thought to be unsuitable by the investigator. 5)Patients who underwent radiation therapy.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Complete en block resection rate
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie ESD's efficacy in superficial pharyngeal cancer as studied in JPRN-UMIN000003623?
How does ESD compare to transoral robotic surgery for curative resection of early-stage pharyngeal squamous cell carcinoma?
Which histological or genetic biomarkers predict successful ESD outcomes in superficial pharyngeal tumors?
What are the safety profiles and management strategies for ESD-related complications in pharyngeal cancer patients?
Are there combination therapies with ESD for superficial pharyngeal cancer, such as adjuvant immunotherapy or targeted agents?